SAREPTA THERAPEUTICS, INC. Other Current Assets
SAREPTA THERAPEUTICS, INC. (SRPT) had Other Current Assets of $105.78 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-05
- 2026-06-30: Other Assets, Current $105.78M.
- 2026-03-31: Other Assets, Current $187.97M.
- 2025-12-31: Other Assets, Current $171.86M.
- 2025-09-30: Other Assets, Current $192.35M.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $105.78M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $187.97M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $171.86M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $192.35M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $127.59M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $105.48M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $90.46M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $165.48M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $74.74M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $82.97M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $77.71M 10-K · filed 2025-02-28 | $179.90M 10-K · filed 2024-02-28 |
| 2023-09-30 | $154.44M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $148.22M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $179.77M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $149.89M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $130.74M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $129.33M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $140.33M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $149.03M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $147.94M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $141.67M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $174.98M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $213.32M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $164.62M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $114.44M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $96.15M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $81.91M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $79.02M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $110.80M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $136.24M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $77.78M 10-K · filed 2020-02-26 | |
| 2018-09-30 | $54.80M 10-Q · filed 2018-10-31 | |
| 2018-06-30 | $42.99M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $31.20M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $36.51M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $27.03M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $28.57M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $22.74M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $26.89M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $22.00M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $15.30M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $16.89M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $17.38M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $19.47M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $23.09M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $24.41M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $35.04M 10-K · filed 2016-02-25 | |
| 2014-09-30 | $26.44M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $15.91M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $9.08M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $3.06M 10-K · filed 2015-02-26 | |
| 2013-09-30 | $2.81M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $5.68M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $3.02M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $1.53M 10-K · filed 2014-03-03 | |
| 2012-09-30 | $1.70M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $1.56M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $1.92M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $1.65M 10-K · filed 2013-03-15 | |
| 2011-09-30 | $1.32M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $943.00K 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $1.02M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |